Among the top 40 significantly up-regulated genes after fisetin treatment of both hepatic and pancreatic cancer cell lines is Axon guidance protein Semaphorin 3E (SEMA3E). The gene discussed is SEMA3E; the disease is familial pancreatic carcinoma.